GoodRx Holdings GDRX 深 沪
已收盘 08-01 16:00:00 美东时间
4.53
-0.260
-5.43%
华盛通- 最 高4.712
- 今 开4.71
- 成交量 69.80万股
- 最 低 4.51
- 昨 收 4.79
- 总市值 16.17亿
- 52周最高 8.80
- 市盈率 静 108.37
- 换手率 0.20%
- 52周最低 3.675
- 委 比 -26.72%
- 总股本 3.57亿
- 历史最高 64.219
- 量 比 0.97
- 振 幅 4.22%
- 历史最低 3.675
- 每 手 1
- 风险率 0.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多A Look at Waystar Holding's Upcoming Earnings Report
Waystar Holding (NASDAQ:WAY) will release its quarterly earnings report on Wedn...
07-30 03:01
Reported Earlier: GoodRx Launches Affordable, All-In-One Erectile Dysfunction Subscription Service Starting At $18/Month
The all-in-one solution includes virtual consultation, FDA-approved prescription medication, and discreet home delivery, with no hidden fees, in-person visits, or memberships requiredGoodRx (NASDAQ:GDRX), the leading
06-10 23:35
GoodRx launches new subscription service focused on erectile dysfunction treatments
Shares of GoodRx (NASDAQ:GDRX) traded higher on Tuesday after the drug savings platform announced the launch of a new subscription service focused on treatments for erectile dysfunction (ED). The new ...
06-10 22:39
Goodrx Announces Launch Of A New Offering for Independent Community Pharmacies, Goodrx Community Link, In June 2025
GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced that it will launch a new offering for independent community pharmacies - GoodRx Community Link - in June 2025. GoodRx
05-22 21:05
GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst
J.P. Morgan analyst revises outlook on GoodRx Holdings following Q1 earnings, reaffirms Overweight rating and $7 price target.
05-20 02:14
KeyBanc Remains a Buy on GoodRx Holdings (GDRX)
KeyBanc analyst Scott Schoenhaus maintained a Buy rating on GoodRx Holdings (GD...
05-14 15:59
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
UBS Maintains Neutral on GoodRx Holdings, Lowers Price Target to $5.25
UBS analyst Kevin Caliendo maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the price target from $6 to $5.25.
05-13 23:52
美股大行评级 | 潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
潜在涨幅754.7%！HC Wainwright & Co.：Alector获机构升目标价至10美元，维持"买入"评级
05-10 10:00
快讯 | GoodRx Holdings Inc : 美国银行全球货币研究将目标价格从4美元下调至4.75美元
GoodRx Holdings Inc : BofA Global Research Cuts Price Objective to $4 From $4.75
05-08 19:19
